SCHEMBL5334361

Drug
SCHEMBL5334361
Identifiers
  • 7-[(3-methoxyphenoxy)methyl]-2,3,4,5-tetrahydro-1H-3-benzazepine
CAS Number
  • 959867-47-1 checkY
PubChem CID
  • 59027940
Chemical and physical data
FormulaC18H21NO2
Molar mass283.371 g·mol−1
3D model (JSmol)
  • Interactive image
  • COC1=CC(=CC=C1)OCC2=CC3=C(CCNCC3)C=C2
InChI
  • InChI=1S/C18H21NO2/c1-20-17-3-2-4-18(12-17)21-13-14-5-6-15-7-9-19-10-8-16(15)11-14/h2-6,11-12,19H,7-10,13H2,1H3
  • Key:BFCIUKMUJQOSDE-UHFFFAOYSA-N

SCHEMBL5334361 is a drug which acts as an agonist at the 5-HT2 family of serotonin receptors, and was developed for the treatment of glaucoma. It is a benzazepine derivative structurally related to the anorectic drug lorcaserin. It is selective for 5-HT2A, with an EC50 of 0.4nM at 5-HT2A vs 3.9nM at 5-HT2C and a much lower affinity of 417nM at 5-HT2B.[1]

See also

  • 3C-BZ
  • AAZ-A-154
  • AL-34662
  • GSK-189254
  • IHCH-7113
  • O-4310
  • WAY-470

References

  1. ^ WO 2007149728, Mohapatra S, Hellberg MR, Feng Z, "Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma", assigned to Alcon Manufacturing, Ltd. 
  • v
  • t
  • e
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

  • v
  • t
  • e